| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 157.77B | 162.01B | 177.97B | 191.28B | 168.34B | 144.57B |
| Gross Profit | 42.73B | 42.49B | 51.34B | 54.79B | 50.88B | 42.87B |
| EBITDA | 23.19B | 22.60B | 30.39B | 34.43B | 34.91B | 29.11B |
| Net Income | 9.94B | 7.80B | 9.73B | 16.87B | 14.16B | 13.49B |
Balance Sheet | ||||||
| Total Assets | 359.22B | 345.30B | 328.51B | 296.40B | 282.64B | 256.92B |
| Cash, Cash Equivalents and Short-Term Investments | 25.66B | 21.50B | 23.13B | 32.20B | 30.64B | 17.83B |
| Total Debt | 118.05B | 84.71B | 53.59B | 24.99B | 27.49B | 28.23B |
| Total Liabilities | 175.25B | 134.16B | 107.48B | 79.63B | 81.91B | 71.40B |
| Stockholders Equity | 182.15B | 209.37B | 219.26B | 215.20B | 199.22B | 183.83B |
Cash Flow | ||||||
| Free Cash Flow | -4.08B | -14.31B | -21.10B | 8.51B | 15.99B | 13.83B |
| Operating Cash Flow | 24.63B | 29.52B | 11.60B | 22.74B | 28.58B | 26.70B |
| Investing Cash Flow | -22.09B | -39.44B | -34.29B | -11.10B | -11.00B | -3.88B |
| Financing Cash Flow | -2.20B | 8.44B | 12.13B | -10.48B | -6.11B | -12.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥352.23B | 14.16 | 9.59% | 3.91% | 0.87% | 16.71% | |
76 Outperform | ¥418.03B | 17.67 | 6.52% | 1.82% | 3.25% | -11.31% | |
74 Outperform | ¥165.78B | 14.73 | ― | 2.84% | 6.06% | 19.76% | |
74 Outperform | ¥302.60B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
68 Neutral | ¥2.07T | 17.01 | 11.98% | 1.54% | 1.84% | -6.57% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥163.74B | 9.97 | 4.24% | 3.76% | -7.81% | 25.04% |